Juliana Suso Jaramillo
Corporate Officer/Principal at INTERCONEXIÓN ELÉCTRICA S.A. E.S.P.
Profile
Juliana Suso Jaramillo is currently the Chief Institutional Relations Officer at Interconexion Eléctrica SA ESP.
Previously, she worked as a Business Manager at Wyeth, Inc. and as a General Manager at Tour Vacation Hoteles Azul SAS from 2011 to 2013.
She also served as a Manager-New Products at Bayer SA (Colombia).
Ms. Suso Jaramillo obtained her undergraduate degree from The Methodist University, Inc.
Juliana Suso Jaramillo active positions
Companies | Position | Start |
---|---|---|
INTERCONEXIÓN ELÉCTRICA S.A. E.S.P. | Corporate Officer/Principal | 2020-09-27 |
Former positions of Juliana Suso Jaramillo
Companies | Position | End |
---|---|---|
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ BiotechnologyHealth Technology Part of Johnson & Johnson, Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ is a private company that manufactures biopharmaceutical products. The company is based in New York, NY. Wyeth, Inc. /Biopharmaceutical Manufacturing Operations was acquired by Centocor, Inc. from Wyeth LLC on April 06, 2004. | Corporate Officer/Principal | - |
Bayer SA (Colombia) | Corporate Officer/Principal | - |
Training of Juliana Suso Jaramillo
The Methodist University, Inc. | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INTERCONEXIÓN ELÉCTRICA S.A. E.S.P. | Utilities |
Private companies | 2 |
---|---|
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ BiotechnologyHealth Technology Part of Johnson & Johnson, Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ is a private company that manufactures biopharmaceutical products. The company is based in New York, NY. Wyeth, Inc. /Biopharmaceutical Manufacturing Operations was acquired by Centocor, Inc. from Wyeth LLC on April 06, 2004. | Health Technology |
Bayer SA (Colombia) |
- Stock Market
- Insiders
- Juliana Suso Jaramillo